| Literature DB >> 35383211 |
Krystell Oviedo Flores1,2, Lukas Kaltenegger3, Fabian Eibensteiner3,4, Markus Unterwurzacher3,4, Klaus Kratochwill3,4, Christoph Aufricht3, Franz König5, Andreas Vychytil6.
Abstract
New recommendations on evaluation of peritoneal membrane function suggest ruling out catheter dysfunction when evaluating patients with low ultrafiltration capacity. We introduce the use of a combination of parameters obtained from the cycler software PD Link with HomeChoicePro (Baxter International Inc., Illinois, United States) cyclers for predicting catheter dysfunction in automated peritoneal dialysis patients (APD). Out of 117 patients treated at the Medical University of Vienna between 2015 and 2021, we retrospectively identified all patients with verified catheter dysfunction (n = 14) and compared them to controls without clinical evidence of mechanical catheter problems and a recent X-ray confirming PD catheter tip in the rectovesical/rectouterine space (n = 19). All patients had a coiled single-cuff PD catheter, performed tidal PD, and received neutral pH bicarbonate/lactate-buffered PD fluids with low-glucose degradation products on APD. Icodextrin-containing PD fluids were used for daytime dwells. We retrieved cycler data for seven days each and tested parameters' predictive capability of catheter dysfunction. Total number of alarms/week > 7 as single predictive parameter of catheter dislocation identified 85.7% (sensitivity) of patients with dislocated catheter, whereas 31.6% (1-specificity) of control patients were false positive. A combination of parameters (number of alarms/week > 7, total drain time > 22 min, ultrafiltration of last fill < 150 mL) where at least two of three parameters appeared identified the same proportion of patients with catheter dislocation, but was more accurate in identifying controls (21.1% false positive). In contrast to yearly PET measurements, an easily applicable combination of daily cycler readout parameters, also available in new APD systems connected to remote monitoring platforms shows potential for diagnosis of catheter dysfunction during routine follow-up.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35383211 PMCID: PMC8983779 DOI: 10.1038/s41598-022-09462-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Demographic data and biochemical parameters at the start of the observation period.
| Characteristics | Cases ( | Controls ( | ||
|---|---|---|---|---|
| Age (years), mean (SD) | 57.07 | (13.42) | 49.37 | (15.80) |
| Female | 4 | (28.57) | 7 | (36.84) |
| Male | 10 | (71.43) | 12 | (63.16) |
| Glomerulonephritis | 6 | (42.86) | 5 | (26.32) |
| Polycystic kidney disease | 1 | (7.14) | 4 | (21.05) |
| Vascular nephropathy | 2 | (14.29) | 1 | (5.26) |
| Diabetic nephropathy | 2 | (14.29) | 4 | (21.05) |
| Glomerular amyloidosis | 0 | (0.00) | 2 | (10.53) |
| Other/unknown | 3 | (21.43) | 3 | (15.79) |
| Comorbidities | ||||
| Cardiovascular history | 5 | (35.71) | 9 | (47.37) |
| Hypertension | 10 | (71.43) | 12 | (63.16) |
| Diabetes | 4 | (28.57) | 6 | (31.58) |
| Time on PD (months), median (IQR) | 3.0 | (8.89) | 3.0 | (0.00) |
| D/P Creatinine | 0.81 | (0.09) | 0.80 | (0.12) |
| GFRa (ml/min/1.73 m2) | 4.60 | (1.90) | 4.30 | (2.50) |
| Weekly Kt/V | 2.03 | (0.29) | 2.28 | (0.45) |
| Weekly CCr (L/week/1.73 m2) | 72.39 | (15.69) | 78.74 | (26.20) |
| Serum creatinine (mg/dL) | 7.93 | (2.40) | 7.67 | (2.65) |
| BUN (mg/dL) | 52.87 | (17.37) | 49.96 | (15.66) |
| Serum calcium (mmol/L) | 2.16 | (0.13) | 2.22 | (0.13) |
| Serum phosphate (mmol/L) | 1.89 | (0.60) | 1.65 | (0.57) |
| Albumin (g/L) | 34.76 | (4.31) | 33.55 | (6.02) |
| Hemoglobin (g/dL) | 10.18 | (1.09) | 10.62 | (1.35) |
| WBC (G/L) | 6.54 | (1.37) | 6.13 | (1.67) |
aThe mean GFR was calculated as average value of creatinine and urea clearance using 24-h urine collections. For all parameters, P values > 0.05 when comparing cases vs controls (two-tailed MWU test). BUN, blood urea nitrogen; CCr, creatinine clearance; GFR, glomerular filtration rate; WBC, white blood cell counts.
APD treatment parameters.
| Parameter | Cases ( | Controls ( | ||
|---|---|---|---|---|
| Last fill volume with icodextrin (mL), median (IQR) | 1000 | (125) | 1000 | (500) |
| Treatment volume a (mL), median (IQR) | 9500 | (0) | 9500 | (4500) |
| Fill volume (mL), median (IQR) | 2000 | (315) | 1997 | (501) |
| Drain volume (mL), median (IQR) | 2080 | (384) | 2065 | (1062) |
| Tidal volume (%),median (IQR) | 57.5 | (30.0) | 60.0 | (20.0) |
| Tidal volume (mL), median (IQR) | 1090 | (525) | 1200 | (600) |
| Daily glucose load b (g/day), median (IQR) | 124.1 | (8.0) | 132.0 | (73.6) |
All patients performed tidal PD and received icodextrin-containing PD fluid for the daytime dwell, except for one patient in the control group who performed nightly intermittent PD without last fill. For all parameters, P values > 0.05 when comparing cases vs controls (two-tailed MWU test), except for daily glucose load (P = 0.0471).
aLast fill with icodextrin excluded.
bDaily glucose load was calculated as the total glucose in the fresh PD fluid infused each day in grams.
Figure 1Receiver operator characteristic (ROC) curves for the parameters obtained from APD cycler card management software in the cases and the controls. The arrow indicates the point corresponding to the cut-off value selected. AUC = area under the curve. (a) Total number of alarms per week; (b) total drain time at the end of cycler session; (c) mean net UF of last fill; (d) days with negative UF of last fill; (e) mean gcUF during cycler treatment (*not included in further analysis).
Summary of simple and stepwise logistic regression of the parameters for predicting catheter dislocation.
| Parameter | Simple logistic regression | Stepwise logistic regression | ||||
|---|---|---|---|---|---|---|
| AUC | OR | ß-coefficient | OR | |||
| Total alarms | 0.87 [0.73–1.00] | 1.298 [1.062; 1.586] | 0.011 | 0.261 | 1.298 [1.062; 1.586] | 0.011 |
| Total drain time (min) | 0.82 [0.66–0.99] | 1.125 [1.015; 1.247] | 0.025 | 0.117 | NC | |
| Net UF last fill (mL)a | 0.79 [0.63–0.95] | 0.994 [0.989; 0.999] | 0.013 | -0.006 | NC | |
| Days with negative UF last fill | 0.68 [0.48–0.88] | 1.345 [0.984; 1.839] | 0.063 | 0.296 | NC | |
aCorresponding to daytime dwell. AUC, area under the curve; CI, confidence interval; NC, no candidate; OR, odds ratio; SE, standard error.
Combination of the most promising parameters for identifying patients with catheter dysfunction in the cases and the controls.
| Only alarms as criterion fulfilled | At least 1 of 3 criteria fulfilled | At least 2 of 3 criteria fulfilled | 3 of 3 criteria fulfilled | |
|---|---|---|---|---|
Number of alarms > 7, Drain time > 22 min, UF last fill < 150 mL | ||||
| Cases correctly identified | 85.7% | 100% | 85.7% | 71.4% |
| False positive controls | 31.6% | 57.9% | 21.1% | 5.3% |
Number of alarms > 7, Drain time > 22 min, Days with negative UF last fill > 2 | ||||
| Cases correctly identified | 85.7% | 100% | 78.6% | 57.1% |
| False positive controls | 31.6% | 52.6% | 15.8% | 5.3% |
Figure 2Flow chart of cases and controls selection.